TY - JOUR
T1 - PTPA variants and impaired PP2A activity in early-onset parkinsonism with intellectual disability
AU - French and Mediterranean Parkinson disease Genetics Study Group
AU - International Parkinsonism Genetics Network
AU - Fevga, Christina
AU - Tesson, Christelle
AU - Carreras Mascaro, Ana
AU - Courtin, Thomas
AU - Van Coller, Riaan
AU - Sakka, Salma
AU - Ferraro, Federico
AU - Farhat, Nouha
AU - Bardien, Soraya
AU - Damak, Mariem
AU - Carr, Jonathan
AU - Ferrien, Melanie
AU - Boumeester, Valerie
AU - Hundscheid, Jasmijn
AU - Grillenzoni, Nicola
AU - Kessissoglou, Irini A.
AU - Kuipers, Demy J.S.
AU - Quadri, Marialuisa
AU - Agid, Yves
AU - Anheim, Mathieu
AU - Borg, Michel
AU - Brice, Alexis
AU - Broussolle, Emmanuel
AU - Corvol, Jean Christophe
AU - Damier, Philippe
AU - Defebvre, Luc
AU - Dürr, Alexandra
AU - Durif, Franck
AU - Houeto, Jean Luc
AU - Krack, Paul
AU - Klebe, Stephan
AU - Lesage, Suzanne
AU - Lohmann, Ebba
AU - Martinez, Maria
AU - Mangone, Graziella
AU - Mariani, Louise Laure
AU - Pollak, Pierre
AU - Rascol, Olivier
AU - Tison, François
AU - Tranchant, Christine
AU - Verin, Marc
AU - Viallet, François
AU - Vidailhet, Marie
AU - Lohmann, Ebba
AU - Emre, Murat
AU - Hanagasi, Hasmet
AU - Bilgic, Basar
AU - Lu, Bedia Marangozog
AU - Benmahdjoub, Mustapha
AU - Yeh, Tu Hsueh
N1 - Publisher Copyright:
© 2022 The Author(s). Published by Oxford University Press on behalf of the Guarantors of Brain.
PY - 2023/4/1
Y1 - 2023/4/1
N2 - The protein phosphatase 2A complex (PP2A), the major Ser/Thr phosphatase in the brain, is involved in a number of signalling pathways and functions, including the regulation of crucial proteins for neurodegeneration, such as alpha-synuclein, tau and LRRK2. Here, we report the identification of variants in the PTPA/PPP2R4 gene, encoding a major PP2A activator, in two families with early-onset parkinsonism and intellectual disability. We carried out clinical studies and genetic analyses, including genome-wide linkage analysis, whole-exome sequencing, and Sanger sequencing of candidate variants. We next performed functional studies on the disease-associated variants in cultured cells and knock-down of ptpa in Drosophila melanogaster. We first identified a homozygous PTPA variant, c.893T>G (p.Met298Arg), in patients from a South African family with early-onset parkinsonism and intellectual disability. Screening of a large series of additional families yielded a second homozygous variant, c.512C>A (p.Ala171Asp), in a Libyan family with a similar phenotype. Both variants co-segregate with disease in the respective families. The affected subjects display juvenile-onset parkinsonism and intellectual disability. The motor symptoms were responsive to treatment with levodopa and deep brain stimulation of the subthalamic nucleus. In overexpression studies, both the PTPA p.Ala171Asp and p.Met298Arg variants were associated with decreased PTPA RNA stability and decreased PTPA protein levels; the p.Ala171Asp variant additionally displayed decreased PTPA protein stability. Crucially, expression of both variants was associated with decreased PP2A complex levels and impaired PP2A phosphatase activation. PTPA orthologue knock-down in Drosophila neurons induced a significant impairment of locomotion in the climbing test. This defect was age-dependent and fully reversed by L-DOPA treatment. We conclude that bi-allelic missense PTPA variants associated with impaired activation of the PP2A phosphatase cause autosomal recessive early-onset parkinsonism with intellectual disability. Our findings might also provide new insights for understanding the role of the PP2A complex in the pathogenesis of more common forms of neurodegeneration.
AB - The protein phosphatase 2A complex (PP2A), the major Ser/Thr phosphatase in the brain, is involved in a number of signalling pathways and functions, including the regulation of crucial proteins for neurodegeneration, such as alpha-synuclein, tau and LRRK2. Here, we report the identification of variants in the PTPA/PPP2R4 gene, encoding a major PP2A activator, in two families with early-onset parkinsonism and intellectual disability. We carried out clinical studies and genetic analyses, including genome-wide linkage analysis, whole-exome sequencing, and Sanger sequencing of candidate variants. We next performed functional studies on the disease-associated variants in cultured cells and knock-down of ptpa in Drosophila melanogaster. We first identified a homozygous PTPA variant, c.893T>G (p.Met298Arg), in patients from a South African family with early-onset parkinsonism and intellectual disability. Screening of a large series of additional families yielded a second homozygous variant, c.512C>A (p.Ala171Asp), in a Libyan family with a similar phenotype. Both variants co-segregate with disease in the respective families. The affected subjects display juvenile-onset parkinsonism and intellectual disability. The motor symptoms were responsive to treatment with levodopa and deep brain stimulation of the subthalamic nucleus. In overexpression studies, both the PTPA p.Ala171Asp and p.Met298Arg variants were associated with decreased PTPA RNA stability and decreased PTPA protein levels; the p.Ala171Asp variant additionally displayed decreased PTPA protein stability. Crucially, expression of both variants was associated with decreased PP2A complex levels and impaired PP2A phosphatase activation. PTPA orthologue knock-down in Drosophila neurons induced a significant impairment of locomotion in the climbing test. This defect was age-dependent and fully reversed by L-DOPA treatment. We conclude that bi-allelic missense PTPA variants associated with impaired activation of the PP2A phosphatase cause autosomal recessive early-onset parkinsonism with intellectual disability. Our findings might also provide new insights for understanding the role of the PP2A complex in the pathogenesis of more common forms of neurodegeneration.
KW - intellectual disability
KW - parkinsonism
KW - PP2A
KW - PPP2R4
KW - PTPA
UR - http://www.scopus.com/inward/record.url?scp=85152396974&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85152396974&partnerID=8YFLogxK
U2 - 10.1093/brain/awac326
DO - 10.1093/brain/awac326
M3 - Article
C2 - 36073231
AN - SCOPUS:85152396974
SN - 0006-8950
VL - 146
SP - 1496
EP - 1510
JO - Brain
JF - Brain
IS - 4
ER -